title: Fluctuating antibody response in a cohort of hepatitis C patients.
abstract: OBJECTIVE
  This project was designed to longitudinally study persons who had antibodies to hepatitis C virus (HCV) to characterise the serologic course of infection.
  
  
  METHODS
  The subjects were 149 multitransfused patients (141 with thalassaemia major, 3 with thalassaemia intermedia, and 5 with sickle cell anaemia) who had been regularly followed up for 3 to 7 years. Sequential serum samples obtained semi-annually between January 1994 and January 2001 were tested, prospectively, by second or third generation HCV enzyme-linked immunosorbent assay (ELISA), followed by confirmatory recombinant immunoblot assay (RIBA-2 or RIBA-3).
  
  
  RESULTS
  Of the 149 patients, 90 did not seroconvert to HCV, whereas 59 had detectable antibodies. On the basis of RIBA results in these 59 patients, 24 (41%) had persistent high antibody levels to structural and non structural HCV antigens, 11 (19%) had persistent low antibody levels, 17 (29%) showed fluctuating antibody levels, and in 5 patients (8%) there was a total or a partial disappearance of specific antibodies (seroreversion), mainly anti-core antibodies. Two patients (3%) had antibody responses that did not fit into any of these four categories. In patients with fluctuating antibody levels, there were periods ranging from 6 months to 2 years when anti-HCV antibodies could not be detected.
  
  
  CONCLUSIONS
  This study shows that the antibody response to HCV in patients who receive frequent blood transfusions is very variable. Individuals who exhibit intermittent seropositivity are a challenge to diagnosis.
authors.affiliation: Departments of Microbiology and Immunology, and.
authors.forename: Said H S
authors.initials: SH
authors.lastname: Al Dhahry
authors.forename: Shahina
authors.initials: S
authors.lastname: Daar
authors.forename: Jameel C
authors.initials: JC
authors.lastname: Nograles
authors.forename: Situsekara M W W B
authors.initials: SM
authors.lastname: Rajapakse
authors.forename: Fadhila S S
authors.initials: FS
authors.lastname: Al Toqi
authors.forename: Geraldine Z
authors.initials: GZ
authors.lastname: Kaminski
keywords: antibody response; hepatitis C virus; thalassaemia
references.citation: Transfusion. 1995 Sep;35(9):745-9
references.pmid: 7570934
references.citation: Semin Hematol. 1995 Oct;32(4):280-7
references.pmid: 8560285
references.citation: J Med Virol. 1993 Nov;41(3):215-20
references.pmid: 7505306
references.citation: N Engl J Med. 1995 Jun 1;332(22):1463-6
references.pmid: 7739682
references.citation: Lancet. 1992 Apr 25;339(8800):1018-9
references.pmid: 1349053
references.citation: Semin Liver Dis. 1999;19 Suppl 1:3-15
references.pmid: 10349688
references.citation: Am J Kidney Dis. 1996 Sep;28(3):437-40
references.pmid: 8804244
references.citation: Transfusion. 1993 Aug;33(8):634-8
references.pmid: 7688158
references.citation: Nephrol Dial Transplant. 1995;10(2):234-9
references.pmid: 7538650
references.citation: Lancet. 1994 Nov 26;344(8935):1475-9
references.pmid: 7968123
references.citation: J Infect Dis. 1997 Feb;175(2):316-22
references.pmid: 9203652
references.citation: Semin Liver Dis. 2000;20(1):17-35
references.pmid: 10895429
references.citation: Science. 1992 Oct 2;258(5079):135-40
references.pmid: 1279801
references.citation: Science. 1989 Apr 21;244(4902):359-62
references.pmid: 2523562
references.citation: Clin Diagn Lab Immunol. 1995 Mar;2(2):219-24
references.pmid: 7697532